Needle phobia: confronting a neglected factor in travel vaccine hesitancy

Clicks: 2
ID: 339985
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #82 of 83 articles by views in international journal of travel medicine and global health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
BACKGROUND: Patients with needle phobia present with disproportionate fear, anxiety, or avoidance of needles that can disrupt access to healthcare services. Needle phobia creates a barrier to public health measures including travel vaccine uptake. This narrative review analyses these challenges by examining the psychological, sociocultural, and clinical determinants of needle phobia and how they can be addressed in travel medicine practice. METHODS: The literature search was performed using PubMed, Scopus, and Google Scholar databases. Only articles published in English were included, with a focus on work published in the last 10 years to align with advancements in vaccine technology and psychological interventions for needle phobia. Key data extracted from studies included population characteristics, prevalence and severity of needle phobia, intervention strategies, vaccine hesitancy trends, and emerging vaccine technologies. RESULTS: Individuals with needle phobia are twice as likely to be vaccine hesitant as non-phobic individuals. Needle phobia often originates from a learned fear response, with 62-81% beginning in childhood, decreases with age, and has a higher prevalence among females (up to two-fold). Prior fainting is more than twice as common in travellers who fear injections (16.5% vs 6.9%). Therapeutic support includes pain management techniques that minimise the physical and psychological discomfort associated with vaccination, distraction interventions, graduated exposure therapy, and applied tension that counteracts vasovagal syncope by using muscle tension techniques. Non-injection vaccine modalities such as oral, intranasal, and microarray patch vaccines may alleviate needle phobia and enhance vaccine compliance. Advances in vaccination technology have the potential to revolutionise how vaccines are administered in travel medicine practice. CONCLUSIONS: Needle phobia represents a significant and often overlooked barrier to vaccine uptake. Addressing this issue requires the integration of both clinical and psychological interventions, along with the adoption of promising technological advancements in vaccine delivery.
Reference Key
openalex_W7232933732 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal international journal of travel medicine and global health
Year 2026
DOI
10.1093/jtm/taag107
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.